today. call Ralph. and you Thanks, joining everyone, Good for morning, thank our
global stakeholders. As challenges, addressing changing the customers of all with we to patients continue remained our and the and balancing step Throughout of pressures and treatment our new protocols landscape face a have variants, these we testing and clients, into rapidly on evolving economy. COVID on XXXX, changing focused needs
organization share our dividends get $X XXXX second Brian will we that, result, of about a share repurchases. ahead. for growth in financial to to grow and world and our full of year delivered for provide questions. billion, long-term deliver started. those our continue your and returned value I'll see consecutive our year the XXXX let's outlook. XX,XXX-plus XX% serve and grew and we'll to And we full and target. differentiated year in growth billion a opportunities XXXX, continue shareholders Then Today, results colleagues We $XXX over share year a In we $XX.XX, adjusted we XXXX sustained around earnings performance additional With the growth our our take adjusted As to above revenues per our also to around details perspective the businesses.
Additionally, capabilities we ensure in we growth continue for beyond. positioned to our in and sustained to are invest XXXX
includes U.S. intelligence fueled be Cigna and business, high-performing which Healthcare, Government of portfolio our pharmacy, U.S. services and will is platforms: our services; Our two growth commercial, care, Health International including to and Evernorth, businesses. health benefits by and our continue
capabilities multiple each Cigna and to and Evernorth groups. other breadth their through the Our Healthcare ability of serve platforms buyer complement the
with build services. or new solution on pharmacy medical typically those then and we lead innovating Here, by either delivering and relationships a we
to a portfolio. high-performing approach, diverse, to sustained this with portfolio expand of record continued that a and track proven a have solutions We innovation commitment
so include this in valuable as clients; area positioned our pressure new partnerships. been growth portfolio. a another in a Relative one are dynamic for broadening and temporary for environment. are health in extremely in we We that business deeper further have portfolio, services discuss core which as compensate accelerated to detail virtual our dermatology pharmacy our within generate can Additionally, see and it reach XXXX health through very of We corporate to and partners and Evernorth's care health revenues through just a health I'll system recognized as as well grew value XX% services, governmental adjusted healthcare in Evernorth. clients, XXXX delivery the results in was increasingly agencies strong for our plans, year in performance, capabilities, MDLIVE we our our behavioral business, services; specialty in our which including in which more outstanding pharmacy continues to our urgent expanded moment, by
our and For leveraging had U.S. the strength of Health Cigna U.S. Government Commercial, sustained growth, businesses. International we Healthcare,
the we The and we impact treatment previously special within year. elevated throughout our higher period for experienced elevated trend in As continued stop-loss claims costs the commercial claims COVID the and medical from of elevated costs. discussed, our testing also vaccines. These businesses business. We insured of continued higher had included costs enrollment individual customers
XXXX. XX% a for year As ratio Healthcare medical result, Cigna was our full care for
margin for discuss in continue we as and to XXXX Brian prioritize for As in we expansion detail, further took pricing impact, targeted affordability will XXXX. XXXX actions earlier
breadth billion our nature our and enabled and and earlier, $X shareholders. return highlighted complementary I As of us the capital to portfolio EPS revenue our exceed outlook to over of
of to attractive on sustained growth We performance. are reshaping Looking to pharmacological between opportunities sites continue opportunities to respond on additional and that and and healthcare. of forward fundamentally the third, achieve to the health; growth Evernorth trend capitalize of are trend, forces toward lead by to how capabilities physical They care. XXXX, we Evernorth the emerging innovation, growing the we increased way to pharmacological the future capitalize alternative start three the drive expect innovation. I'll first leveraging will mental to highlighting see believe link by recognition
coming innovative expire, pharmaceuticals, to promising and opening patents significant and new and in drugs predictable. therapies XXXX, that growth for biologic ways potentially have gene in accessible, for door And billion. Evernorth example, on decrease will estimated most life-changing affordable one we're for and affordability. to patients are pressures biosimilar These the of intensifying by therapies medical the XX the increasing market provide opportunity the spending This for By seeing vaccines. areas competition opportunity with currently also an clients an represent increased $XXX in drugs most dramatic bring the and healthcare innovation specialty New advances customers, in good the life-saving years. creates
Importantly, XXXX. this already will in unfolding and accelerate trend XXXX in is further
by clients savings pharmacy our which those drives only also for positioned to our combining fastest-growing large one specific already conditions. highlight benefit that lead X/X of capabilities today our health number fully a the coordinating differentiated of are is patients capture Accredo intend pharmacy customers, a and service We to our for the and parts of and capability, provides care portfolio. of include Evernorth Accredo specialty and portion revenue, of of I'd specialty that
just biologics illustrates capabilities way incentives draws delivering priority included customers. and for leverage as integrated will Healthcare in for Healthcare well to capabilities. rapidly launched an Evernorth's well one focus improved and medical leverage that biosimilars clients care also supply drive continue access program and for as for chain will demand significant health This we Cigna drugs and we affordability Last as benefit from also customers. continue models. to grow Scripts, Express Additionally, leveraging clinical expertise Cigna innovative its Managing affordability, upon services leveraging which as that improve expertise service a changing business. a network, the the year, to greater in mental broad more specialty to and value our access clients is to Evernorth the
our for care expanding We important MDLIVE how is as example, as well well patients services as virtual our know by Evernorth expand behavioral both platform it is leveraging continuing For clients. to as care our network.
sustained reinforces research that are receive total diagnosed Our people, costs conditions behavioral who decrease treatment. coordinated, Evernorth healthcare with when
and to each we and in on our market continue Cigna customer drive affordability we our executing XXXX, earnings growth in actions as For of commercial throughout pricing U.S. Healthcare expect XXXX. segments grow
Additionally, will our partner leverage Evernorth continue to and Healthcare Cigna innovations.
For with and affordable most medical to example, performing digital the connect experiences customers help care. highest continuing our we're expand to
information environment improved to previously, approach, for and business, are XXXX. recent their more conditions diagnosed competitive patients Our as outcomes in guide government choices and musculoskeletal our we In support a U.S. personalized actionable with and into we've healthcare provide developed operating stepping affordability. and highly orthopedic noted we
aided For U.S. Cigna, broad business by of our portfolio, for discipline government for we've prioritized pricing the strength XXXX.
will membership. Medicare For with flat year start Advantage, we the
entering by extended position confident we our Looking growth as to Star's are addressable high, enrollment metrics satisfaction we noted new customer due Plan in ratings & steadily customers the In accelerate to our strong, geographies. are forward expanded previously, meaningfully Family business, in our as XXXX, market part period. and our very our further, to grew XXXX are special Individual
in continue a to this decline surge product continue And long-term positioning adjust expect enter driven that in an customers We we in that XXXX. saw do to XXXX, part and new to for in markets. growth, by price We the enrollment attractive support opportunity. we special will view as our
For counties. new XXXX, we entered three new states XX and
example, services well and to have developing mobile services. for for we'll markets, an sharpening domestic as into our our Health, reach we International these In health X.X With additional go additional globally focus, ability health million the and deeper are the customers. as we continue
such analytics-driven partnerships joint in with nib the innovative key an we our Group service do Health, establishing Australia. Honeysuckle One this ways of venture as with health the will company is
quarterly Now $XX.XX XXXX XX% least at attractive by our reinforces of year whole, strength the dividend and growth our the our growth taken another outlook EPS as and increase be company. our will of of of businesses. a sustained for
reach I before further want markets our is I to over our addressable performance a wrap aspect time. our reinforce positioning key in Now up, sustained strategically of to expand
Here, we We targeted growth and organic to focus proven will strengthen inorganic further see continued leverage platforms. here. partnerships three our opportunities of areas
expanding seek ability Evernorth by service in we to markets additional capabilities. and enhanced government, current is opportunities our further and win our in these First, will growth U.S.
further Life discipline will portfolio. our health for home portfolio. focus divest supplemental example, our our Second, Care business our International behavioral services. capabilities, our the Evernorth on includes, in third, Health, in markets virtual, expand our benefits decision reinforces and And Evernorth and to portion of accident we This several service including to
up. wrap to Now
turn for in year position us returned Looking over in performed Brian. the a EPS repurchase. long-term of sustained delivered continue capital in that, dynamic and dividends call will of We environment. back of and XXXX business, at be growth another growth. XXXX, billion business we With share our across over and I'll our shareholders $XX.XX to our adjusted $X will innovation to to invest to